GLPG

Galapagos NV Share Price

78.83
-0.32 (-0.4%)
Upgrade to Real-Time
Afterhours (Closed)
78.83
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Galapagos NV GLPG NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.32 -0.4% 78.83 20:00:00
Open Price Low Price High Price Close Price Prev Close
79.61 78.28 79.78 78.83 79.15
Bid Price Ask Price Spread News
76.06 82.00 5.94 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,294 218,202  78.83  17,201,875 345,204 93.01 - 274.03
Last Trade Time Type Quantity Stock Price Currency
18:43:23 5  76.05 USD

Galapagos NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 5.16B 65.41M 65.41M  948.20M  -703.66M 2.79 -17.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News Galapagos NV

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

GLPG Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.


Your Recent History
NASDAQ
GLPG
Galapagos ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.